BG

Benjamin Gibson

Director, Alliances at Neuraly

Benjamin Gibson has a diverse work experience spanning various industries. Benjamin began their career as a Project Coordinator at the University of the Sciences in Philadelphia in 2009. From there, they moved on to work as a Project Analyst - Global Development at Regus, where they conducted financial analysis to evaluate potential investment opportunities. In 2013, Benjamin joined the City of Baltimore Mayor's Office of Information Technology as a Quantitative Analyst, where they played a key role in negotiations and developed staffing and fiscal models within the Police Department. In 2014, they joined Johns Hopkins Technology Ventures (JHTV) as a Quantitative Technology Analyst, conducting analysis on technology invented by faculty members and managing the Cohen Translational Engineering Fund. Benjamin later became the Manager of the Commercialization Strategy Group, overseeing a team and the intern development program. Benjamin's most recent position is with Neuraly, Inc. where they have held roles as a Senior Manager, Data Management and currently works as an Associate Director, Alliances.

Benjamin Gibson pursued their education in a sequential manner. Benjamin began their academic journey in 2005 at The Johns Hopkins University, where they studied International Studies, Mathematics, and Russian. Benjamin successfully completed their Bachelor of Arts (BA) degree in 2009. Subsequently, they enrolled at The London School of Economics and Political Science (LSE) in the year 2010 and completed a Master of Science (MSc) degree in Political Science and Political Economy in 2011.

Location

Baltimore, United States

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Neuraly

Neuraly, a startup biotech company, was formed in 2016 following foundational research by world class neuroscientists led by Ted Dawson, M.D., Ph.D., Leonard and Madlyn Abramson Professor in Neurodegenerative Diseases and Director of the Institute for Cell Engineering at the Johns Hopkins School of Medicine. Following the acquisition of exclusivelicenses to patents covering the composition of matter and methods of use, research supporting the development of NLY01 was recently published in Nature Medicine1. These data demonstrated the critical role of the glial compartment of the neural tissue in the pathogenesis of neurodegenerative diseases such as Parkinson's and Alzheimer's diseases.


Employees

11-50

Links